This synergistic effect was not observed with URCCA4.3 tumor cells in vitro, suggesting the benefits of PXS-5505 were dependent on alterations in the TME of iCCA rather than direct cytotoxicity of tumor cells (Supplemental Figure S17, http://links.lww.com/HC9/A993). Here, PRRT2 is linked to neoplasm.